References
LDL-C reduction
REGRESSION, BLOOD
Study timeline.CONSORT (Consolidated Standards of Reporting Trials) flow diagram modified for crossover clinical studies.Quantitative composition of the active treatment tested in the clinical study.e.q. = enough quantity.Anthropometric, hemodynamic, and blood chemistry parameters before and after the run-in period, expressed as mean ± standard deviation (SD).DBP = Diastolic blood pressure; HDL = High-density lipoprotein; LDL = Low-density lipoprotein; SBP = Systolic blood pressure; VLDL = Very-low-density lipoprotein.Anthropometric and hemodynamic parameter changes from the baseline to the end of the clinical trial, expressed as mean ± SD.aMED = Alternate Mediterranean; DBP = Diastolic blood pressure; SBP = Systolic blood pressure.Blood chemistry parameters from the baseline to the end of the clinical trial, expressed as mean ± SD.* Multiple regression model investigating the main predictors of LDL-C reduction in the trial.aMED = Alternate Mediterranean; LDL-C = Low-density lipoprotein cholesterol.